Drug Profile
Research programme: cannabinoid prodrugs - Malachite Innovations
Alternative Names: Cannabinoid glycosides -Malachite Innovations; Cannabinosides - Malachite InnovationsLatest Information Update: 30 Dec 2021
Price :
$50
*
At a glance
- Originator Vitality Biopharma
- Developer Malachite Innovations
- Class Antiepileptic drugs; Cannabinoids
- Mechanism of Action Cannabinoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Epilepsy; Guillain-Barre syndrome; Huntington's disease; Inflammatory bowel diseases; Pain; Schizophrenia; Ulcerative colitis
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for preclinical development in Ulcerative-colitis in USA
- 28 Dec 2020 No recent reports of development identified for research development in Pain in USA
- 28 Oct 2020 No recent reports of development identified for preclinical development in Inflammatory-bowel-diseases in USA (IV)